Position in SHC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,714,260
-$1,108,644 QoQ
Shares Held
607,689
+9.1% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
3.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SHC Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Kerrisdale Advisers, LLC holds $10,970,563 across 3 Diagnostics & Research names. SHC ranks #1 (79.4% of the industry book) .
All Filings in SHC
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,714,260 | 607,689 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,822,904 | 556,854 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,510,257 | 795,312 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,843,869 | 795,312 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,273,337 | 795,312 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,879,868 | 795,312 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,281,710 | 795,312 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,489,139 | 967,914 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,624,647 | 967,914 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,776,321 | 876,933 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,149,134 | 744,268 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,046,277 | 639,399 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||